Valine

Valine

SCHEMBL84548

CC(C)[C@H](N)C(=O)O.CC(C)[C@H](N)C(=O)O.NCC(=O)O.NCC(=O)O.O=C(O)[C@@H]1CCCN1

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

SLC5A2

The experimentally established mechanism targets of Valine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC7A5 Q01650 1/20 0.43
NOS2 P35228 2/20 0.34
NOS3 P29474 1/20 0.34
NOS1 P29475 1/20 0.34
PRCP P42785 1/20 0.34
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
ALDH1A1 P00352 1/20 0.33
CYP1A2 P05177 1/20 0.33
THRB P10828 1/20 0.33
ALOX15 P16050 1/20 0.33
CYP2C19 P33261 1/20 0.33
DPP7 Q9UHL4 1/20 0.33
GRIN2D O15399 1/20 0.33
GRIN3B O60391 1/20 0.33
GRIA1 P42261 1/20 0.33
GRIA2 P42262 1/20 0.33
GRIA3 P42263 1/20 0.33
GRIA4 P48058 1/20 0.33
GRIN1 Q05586 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Valine SCHEMBL27639988 1.00 SLC7A5 (0.43) SLC7A5NOS2NOS3NOS1PRCP
Valine SCHEMBL4612513 1.00 SLC7A5 (0.43) SLC7A5NOS2NOS3NOS1PRCP
Valine SCHEMBL27702742 1.00 SLC7A5 (0.43) SLC7A5NOS2NOS3NOS1PRCP
Valine SCHEMBL3498554 1.00 SLC7A5 (0.43) SLC7A5NOS2NOS3NOS1PRCP
Valine SCHEMBL3100209 1.00 SLC7A5 (0.43) SLC7A5NOS2NOS3NOS1PRCP
Valine SCHEMBL4613217 1.00 SLC7A5 (0.43) SLC7A5NOS2NOS3NOS1PRCP
Valine SCHEMBL27683531 1.00 SLC7A5 (0.43) SLC7A5NOS2NOS3NOS1PRCP
Valine SCHEMBL1675269 1.00 SLC7A5 (0.43) SLC7A5NOS2NOS3NOS1PRCP
Valine SCHEMBL3496376 1.00 SLC7A5 (0.43) SLC7A5NOS2NOS3NOS1PRCP
Valine SCHEMBL6514171 1.00 SLC7A5 (0.43) SLC7A5NOS2NOS3NOS1PRCP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116617409-A ASP-ELP for reducing immunogen and enhancing anti-tumor efficacy, and preparation method and application thereof 北京大学 2023-08-22 CN claimed
EP-2594618-B1 SYNTHETIC QUARTZ GLASS SUBSTRATE POLISHING SLURRY AND MANUFACTURE OF SYNTHETIC QUARTZ GLASS SUBSTRATE USING THE SAME SHINETSU CHEMICAL CO (JP) 2017-08-02 EP claimed
US-20160129045-A1 COMPOSITION FOR WOUND-HEALING COMPRISING ADULT STEM CELLS AND ELASTIN-LIKE POLYPEPTIDES DAEGU GYEONGBUK INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2016-05-12 US claimed
EP-1054677-B1 COSMETIC OR DERMATOLOGICAL USE OF 7-HYDROXYLATED STEROIDS ALONE AND/OR IN COMBINATION WITH ELASTIN DERIVED PEPTIDES CONNECTIVE TISSUE IMAGINEERING (US) 2008-10-22 EP claimed
EP-1064010-A4 PEPTIDE COMPOSITIONS AND FORMULATIONS AND USE OF SAME CONNECTIVE TISSUE IMAGINEERING (US) 2004-10-06 EP claimed
US-6777389-B1 INHIBITING CUTANEOUS EFFECTS OF AGING CONNECTIVE TISSUE IMAGINEERING LLC 2004-08-17 US claimed
US-20040034338-A1 Drug delivery devices and methods AMS RESEARCH CORPORATION 2004-02-19 US claimed
EP-0814671-B1 ENVIRONMENTALLY FRIENDLY CHEWING GUM COMPOSITIONS CONTAINING ELASTIC PROTEIN-BASED POLYMERS WRIGLEY W M JUN CO (US) 2003-05-28 EP claimed
EP-1287037-A2 NANOSCALED FUNCTIONAL LAYER Zeppezauer, Michael (DE) 2003-03-05 EP claimed
WO-2001044302-A2 NANOSCALED FUNCTIONAL LAYER ZEPPEZAUER MICHAEL (DE) 2001-06-21 WO claimed
EP-1064010-A1 PEPTIDE COMPOSITIONS AND FORMULATIONS AND USE OF SAME Mrs, Llc (US) 2001-01-03 EP claimed
WO-1999045941-A1 PEPTIDE COMPOSITIONS AND FORMULATIONS AND USE OF SAME MRS, LLC (US) 1999-09-16 WO claimed
EP-4328293-A1 MICROCARRIER AND CELLULAR COMPLEX, AND MEDICAL COMPOSITION, COSMETIC COMPOSITION, MEDICAL PRODUCT, AND COSMETIC PRODUCT COMPRISING SAME Lg Chem, Ltd. (KR) 2024-02-28 EP disclosed
CN-117413048-A Microcarrier, cell complex using same, and medical composition, cosmetic composition, medical product, and cosmetic product 株式会社LG化学 2024-01-16 CN disclosed
CN-116617409-A ASP-ELP for reducing immunogen and enhancing anti-tumor efficacy, and preparation method and application thereof 北京大学 2023-08-22 CN disclosed
WO-2023054901-A1 MICROCARRIER AND CELLULAR COMPLEX, AND MEDICAL COMPOSITION, COSMETIC COMPOSITION, MEDICAL PRODUCT, AND COSMETIC PRODUCT COMPRISING SAME 주식회사 엘지화학 2023-04-06 WO disclosed
WO-2000028996-A1 COSMETIC OR DERMATOLOGICAL USE OF 7-HYDROXYLATED STEROIDS ALONE AND/OR IN COMBINATION WITH ELASTIN DERIVED PEPTIDES MRS, LLC (US) 2000-05-25 WO disclosed
US-5089406-A Method of producing a gene cassette coding for polypeptides with repeating amino acid sequences ALLIED-SIGNAL INC. (US) 1992-02-18 US disclosed
EP-0329710-A1 MICROBIAL PRODUCTION OF PEPTIDE OLIGOMERS ALLIED CORPORATION (US) 1989-08-30 EP disclosed
WO-1988005082-A1 MICROBIAL PRODUCTION OF PEPTIDE OLIGOMERS ALLIED CORPORATION (US) 1988-07-14 WO disclosed